Condition: CNS Embryonal Tumor · CNS, Medulloblastoma · Atypical Teratoid Rhabdoid Tumor · Sponsor: C17 Council
Pilot study to determine feasibility of adding intrathecal chemotherapy and maintenance therapy after high dose chemotherapy for treatment of newly diagnosed HR-EBTs in patients less than 6 years of age.
This description comes directly from the study's public registry record.
Sylvia Cheng · 416-813-7654 · sylvia.cheng@cw.bc.ca
C17 Council · DECRYPT-BABYBRAIN@C17.ca
Always discuss trial participation with your own doctor first.
| Alberta Children's Hospital | Calgary, Alberta, Canada | Recruiting |
| BC Children's Hospital | Vancouver, British Columbia, Canada | Recruiting |
| CancerCare Manitoba (CCMB) | Winnipeg, Manitoba, Canada | Recruiting |
| IWK Health Centre | Halifax, Nova Scotia, Canada | Not Yet Recruiting |
| McMaster Children's Hospital | Hamilton, Ontario, Canada | Recruiting |
| London Health Sciences Centre | London, Ontario, Canada | Recruiting |
| CHU Sainte-Justine | Montreal, Quebec, Canada | Recruiting |
| Montreal Children's Hospital (McGill) | Montreal, Quebec, Canada | Not Yet Recruiting |
| CHU de Québec-Université Laval | Québec, Quebec, Canada | Recruiting |
| Centre hospitalier universitaire de Sherbrooke (CHUS) | Sherbrooke, Quebec, Canada | Recruiting |
| Stollery Children's Hospital | Edmonton, Canada | Recruiting |
| The Hospital for Sick Children | Toronto, Canada | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06942039